Villasan, Alchen S.
HRN: 23-99-45 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2023
CO-AMOXICLAV 625MG (TAB)
11/17/2023
11/24/2023
PO
625mg
BID X 7 Days
S/P NSVD With 2nd Degree RMLE And Repair
Checking Final Appropriateness